Arab Finance: Arab Pharmaceuticals Company generated net profits after tax valued at EGP 134.551 million in the first half (H1) of fiscal year (FY) 2025/2026, an annual leap of 127% from EGP 106.005 million, according to the financial results.
Net sales hit EGP 673.704 million at the end of December 2025, higher by 121% year-on-year (YoY) than EGP 558.129 million.
The basic earnings per share (EPS) stood at EGP 9.80 in H1 FY2025/2026, compared to EGP 15.17 a year earlier.